TGen, Persistent Developing Commercial Version of Biospecimen Management System | GenomeWeb

NEW YORK (GenomeWeb News) – Persistent Systems and the Translational Genomics Research Institute announced they are developing a commercial version of a biospecimen management system.

Called Bio4D, initial versions of the software have been used at TGen in research into the underlying causes of diseases. The partners will now develop a commercial version to manage the collection, processing, storage, distribution, and analysis of biospecimens including blood, DNA, and tissue samples, such as samples from cancer biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.